Audio: D'Arcy v Myriad: The High Court rules on gene patenting


In brief

The High Court unanimously overturned the Full Federal Court's decision in D'Arcy v Myriad Genetics that isolated genetic material was patentable.

Allens Partner Dr Trevor Davies discusses why the High Court overturned the decision and what it means for the biotech industry.

Listen to the interview